Clinical Trial Update: Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating venetoclax in combination with fludarabine, cytarabine, and idarubicin (also known as FLAG-IDA) for induction therapy in ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Fludarabine (Fludarabine)
• Idarubicin (idarubicin)
• Venetoclax (venetoclax)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING